A Randomized Phase II Trial of Capecitabine Plus Vinorelbine Followed by Docetaxel Versus Adriamycin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy for Breast Cancer

机译：卡培他滨加长春瑞滨后加多西他赛与阿霉素加环磷酰胺的随机二期临床试验多西他赛后加多西他赛对乳腺癌的新辅助化疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeGiven the promising activity of capecitabine and vinorelbine in metastatic breast cancer, this randomized phase II trial evaluated the efficacy and safety of this combination as neoadjuvant chemotherapy in breast cancer.

机译：目的鉴于卡培他滨和长春瑞滨在转移性乳腺癌中有希望的活性，该随机II期临床试验评估了该组合作为乳腺癌新辅助化疗的疗效和安全性。

著录项

期刊名称 Cancer Research and Treatment : Official Journal of Korean Cancer Association
作者
Changhoon Yoo; Sung-Bae Kim; Jin-Hee Ahn; Jeong Eun Kim; Kyung Hae Jung; Gyung-Yub Gong; Byung-Ho Son; Sei-Hyun Ahn; Seung Do Ahn; Hak-Hee Kim; Hee Jung Shin; Woo Kun Kim;
展开▼
作者单位

展开▼
年(卷),期 2015(47),3
年度 2015
页码 406–415
总页数 10
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
Breast neoplasm Neoadjuvant therapy Anthracyclines Capecitabine Vinorelbine;

机译：乳腺肿瘤;新辅助疗法;蒽环类药物;卡培他滨;长春瑞滨;

相似文献

外文文献
中文文献
专利

1. Neoadjuvant Vinorelbine–Capecitabine Versus Docetaxel–Doxorubicin–Cyclophosphamide in Early Nonresponsive Breast Cancer: Phase III Randomized GeparTrio Trial [J] . Gunter von Minckwitz Sherko Kümmel Petra Vogel Claus Hanusch Holger Eidtmann Jörn Hilfrich Bernd Gerber Jens Huober Serban Dan Costa Christian Jackisch Sibylle Loibl Keyur Mehta Manfred Kaufmann and On behalf of the German Breast Group Journal of the National Cancer Institute . 2008,第8期

机译：早期无反应性乳腺癌中新辅助长春瑞滨-卡培他滨与多西他赛-阿霉素-环磷酰胺的治疗：III期随机GeparTrio试验
2. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial. [J] . von-Minckwitz G, Kummel S, Vogel P, Journal of the National Cancer Institute . 2008,第8期

机译：新的长春瑞滨-卡培他滨与多西他赛-阿霉素-环磷酰胺在早期无反应性乳腺癌中的疗效：III期随机GeparTrio试验。
3. A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer. [J] . Lee KS, Ro J, Nam BH, Breast cancer research and treatment. . 2008,第3期

机译：多西他赛/卡培他滨与阿霉素/环磷酰胺作为II / III期乳腺癌患者的主要化疗的III期随机试验。
4. Use of Laser Photomodulation in the Evolution of Oral Mucositis Associated to Cyclophosphamide, Methotrexate, 5-Fluouracil - CMF in 5 Fluouracil + Adriamycin + Cyclophosphamide - FAC Chemotherapy Protocols in Patients with Breast Cancer [C] . Maria de Fatima Lima Ferreira, Fabiola Bastos de Carvalho, Susana C. P. S. de Oliveira, Mechanisms for low-light therapy VIII . 2013

机译：激光光调节在5种氟尿嘧啶+阿霉素+环磷酰胺-FAC化疗方案中与环磷酰胺，甲氨蝶呤，5-氟尿嘧啶-CMF相关的口腔黏膜演变中的应用
5. Supportive Care for Patients with Breast Cancer by Using an Interactive App During Neoadjuvant Chemotherapy: A Randomized Controlled Trial [D] . Fjell, Maria. 2021

机译：通过在Neoadjuvant化疗期间使用互动性应用的乳腺癌患者的支持性护理：随机对照试验
6. Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide followed by adjuvant capecitabine/docetaxel vs docetaxel in patients with operable breast cancer [O] . Minmin Zhang, Wei Wei, Jianlun Liu, 2016

机译：在可手术乳腺癌患者中新辅助化疗方案卡培他滨/厄比霉素/环磷酰胺与5-氟尿嘧啶/厄比霉素/环磷酰胺再辅以卡培他滨/多西他赛与多西他赛的疗效和毒性比较
7. Capecitabine combined with docetaxel versus vinorelbine followed by capecitabine maintenance medication for first-line treatment of patients with advanced breast cancer: Phase 3 randomized trial [O] . Jiayu Wang, Binghe Xu, Peng Yuan, 2015

机译：Capecitabine联合多西紫杉醇与血管内血红素，其次是Capecitabine维修药物进行先进乳腺癌患者的一线治疗：第3期随机试验

A Randomized Phase II Trial of Capecitabine Plus Vinorelbine Followed by Docetaxel Versus Adriamycin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy for Breast Cancer

摘要

著录项

相似文献

相关主题

期刊订阅